Expansion!People of Nine Valent

On the evening of August 30, the website of the State Drug Administration showed that the indication of Merida's nine -valent papilloma virus vaccine (brewing yeast) (hereinafter referred to as the nine -valent HPV vaccine) was expanded, and the applicable population expanded to a 9-45 -year -old female vaccination. The vaccine was previously approved for women aged 16-26. On the same day, Merck also released news that the new indication of the Nine -V price HPV vaccine was approved by the State Drug Administration.

It is understood that the nine -valent HPV vaccine uses a three -dose immune program, which is suitable for preventing HPV16, 18, 31, 33, 45, 52, and 58 cervical cancer; HPV6, 11, 16, 18, 31, 33, 45, 52 And the cervical epithelial tumor -like lesions (CIN1/2/3) caused by type 58 and cervical glandular cancer (AIS); and HPV6, 11, 16, 18, 31, 33, 45, 52, and 58 type 58 Continuous infection.

Cervical cancer is one of the common gynecological malignant tumors. In 2021, ICO/IARC's HPV and related diseases in China show that in 2020, among women aged 15-44 in China, the incidence and mortality rate of cervical cancer ranked third in female tumors. In China, about 98%of cervical cancer is caused by high -risk HPV. Although HPV16 and 18 are high -risk HPVs widely popular worldwide, there are differences in China. Popular disease research shows that the most vulnerable HPVs that women in China are most susceptible to infection are HPV16, 52, and 58, respectively. Therefore, inoculation of HPV vaccine for women's age is an important measure to effectively prevent HPV infection and reduce cervical cancer.

As of now, five HPV vaccines have been approved in my country, including three imported HPV vaccines and two domestic vaccines. Among them, in China, the applicable age of imported two-price and quadrimal HPV vaccine is 9-45 years. Before approval, the applicable age of imported nine-valent HPV vaccines is only 16-26. Although the applicable age range of this imported vaccine is expanding, experts still say that inoculation of HPV vaccine does not replace cervical cancer screening, combining vaccination and cervical cancer screening is the best means to prevent cervical cancer. It is recommended that women over 20 years old or more than 3 years of sex per year conduct cervical cancer screening once a year.

Source: Henan Daily

- END -